{"name":"Icosavax, Inc.","slug":"icosavax-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPOUFpajMwU0ctbzJlNDdHbWRReFNpaXdWRW42ZF9DbHhSUkJwN2Y0SFdOdkV4a0s3LVdmWE53bDRfNmQwY204WDEyN29ETDc4QXFiLUZKNkFYQkdDZ1NoU0tSS19ia19lWXVKTUVtMTN4UExnT2lUWk84bjBhdlhDZ1N4aV9jc0w5dmVZNVFwX1ktSDZ6M3RING4xOXFxM2xJNzBqbzdfYlBRZw?oc=5","date":"2024-10-23","type":"pipeline","source":"BioSpace","summary":"Influenza Vaccine Market Size to Surpass USD 18.02 Billion by 2034 - BioSpace","headline":"Influenza Vaccine Market Size to Surpass USD 18.02 Billion by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxOU2ZWYUFNZGRXRDJudmZ4NXRIdVR0TDhmRXRSQllWTGtHQ19iYXNqMHJMYVR0TC04cF94S2N6b3l0XzdKTWxGWXRZbDhkVHJxYzlIbVl1VnZNSEhBdVdCdEhPVEFlSmQ4TGZCYVNxTDlxYjJJblBzQjZxc21MOFlKbUVuZW5POHJIN1pENDRfZ2tmaWhsbFBqOXlMcTROUmxDRzdRc0ozZ0xDdEZYMTdBOTlGYXRUTUdxX2w1cjJXQlRBd091XzBYT3g4d1BsOExGdnhRb0JUQ0xPdzBjWUo1UFhrS0lEaUhrLVlLSA?oc=5","date":"2024-07-05","type":"deal","source":"respiratory-therapy.com","summary":"AstraZeneca to Acquire Icosavax, in-development RSV-hMPV Combo Vaccine - respiratory-therapy.com","headline":"AstraZeneca to Acquire Icosavax, in-development RSV-hMPV Combo Vaccine - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQU184VVAyb2ZPem53MWdDVHhVaXluZlJZLU1mU2pHaWFodGRFdWtiaV9laGJGTFdfS01Fb1hWWVQtbGNBZElhRUZnMjhFcV81NGtseUxqY2JUWk5mdHZocmo4VG1Ra2tQcXFtRjh1alZlcElEZTZxOERVRjZTZGdpekpn?oc=5","date":"2024-02-21","type":"pipeline","source":"PharmTech.com","summary":"AstraZeneca Completes Acquisition of Icosavax - PharmTech.com","headline":"AstraZeneca Completes Acquisition of Icosavax","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPaDdsZUt5N3Q2NnRxbTdxT3E2bVloN2lXUEU3aV81NzV5WWZnMHVvVWx5MmY3TzhxVUg1V1p1WXdxdU56bVZfbFZUc3l1dFdXWjYxZVh2TTJIZ2tkWkYyUVhsUnRIeEdfSmlmNkNMbUtzY0NZZXZhNUgzQ0tLN1RWX1pyaG83T051SHlZbDZKWVpTcUNpbWJnV29KUm0yN011enRRNWFvVFVnQQ?oc=5","date":"2024-02-20","type":"pipeline","source":"The Business Journals","summary":"AstraZeneca completes $1.1B acquisition of UW spinout Icosavax - The Business Journals","headline":"AstraZeneca completes $1.1B acquisition of UW spinout Icosavax","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxObEpUZWJ1VjdxcGxoWVFKdUVvS3dpSXFfM0htNGs3T0puYWVtRlB0SWhpYzA2QVUtSFpQM1RINjVuRmhFYlY5ZVNJSFBYU2ItZXhRWjZHZUJxWUtjZVNiT0x1Y2ZhakRRVUE4QWtXWXVoWklWRDR0T2ZoV1pIMzduamtwd09zdHdvbF9FRU0yWnlmWmtwb1FMZVRzU0w1VUcxWnpNQ01SZXpIa0MyallOeQ?oc=5","date":"2024-02-19","type":"pipeline","source":"AstraZeneca","summary":"Acquisition of Icosavax Completed - AstraZeneca","headline":"Acquisition of Icosavax Completed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNVVxS0thNmdLeXlNOElvdm9PSEt5MjhvcUNNVXBrX0pndkFaVlBRd3otaEx0WTVxRGU4bm5CdFRhSFg5T0ZLOVdoMFJEbFQxYmVxSXNMWUxicGlCdDNoSWVMX1R2YzBuTk1ITGRMbHJWRGs4MjhNRnpMcHRjZTNZTXA0eEtIWXk1NFR5QkF6b0gxb2JVT0xfZ1hTRTJ6UEcybFFKck96Y2h3SmI0V0RzRGw5X3dtNXA0anVOQnh3?oc=5","date":"2023-12-13","type":"deal","source":"Reuters","summary":"AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal - Reuters","headline":"AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQdDBLNnpBbDdCVzJXWjQwYmlmTF9ua1EwQkp0bEFUT2YxNEZWOUZmSmNHMW96WlYtWjg5TVpCb045NWdDcVhESVF6X2hyQ0hjYzhCaXpURDg0cVRYOHNWNTR4YXQwVUEzcVhERzZKNUZONkNOcnN0a2R2aUNoY3A3V0I5dW9EUQ?oc=5","date":"2023-12-13","type":"deal","source":"Pharmaceutical Technology","summary":"AstraZeneca agrees to acquire Icosavax for $1.1bn - Pharmaceutical Technology","headline":"AstraZeneca agrees to acquire Icosavax for $1.1bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNV0pBZ1BnUm5EQmlnWS14NXVoUEpwSF9pa3V6ZlUxSVExRFpMdW1md1VsZ2hGVEUzczlzZnpVUFdMX2J1c191VVhzSHBxMzhpeVV4T3JJNVlPSjZvdV9FOG5pQl9EazJLNGFDbVlJT3owb0t3YUhYZEJNUXl6aWlWYXhzb3ROckpCWmNla0J4ai1HQQ?oc=5","date":"2023-12-12","type":"deal","source":"BioPharma Dive","summary":"AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B - BioPharma Dive","headline":"AstraZeneca to acquire vaccine maker Icosavax for up to $1.1B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNbFJjaUFfSU93VVIxcjNSUVo4RWY2dl9qaWpBUXgyZjFLREFxcmMxVGo1M0w1QVA0SE5IaGs1emJmc1MyempJRTA5eFF1WnptMEczb1p1Y0wxUTVlSnRIbWRTT0tFeVlLbVAzQ3lCak02d2U1NkZPX0lmcm5WLWRDejBDbTA3eGZoQVo5a3dqTmRYZ2hndG1mYXM2Z2x4VjNXZlF2MmlCTV9DbjMtWG1naUxqcy1CRWl0RTBidDlveU5lQlo3NC1NZnF5LTNpbV80Tnl6RUc2YjhLTnpCbjJxSnFBOURZMW1lWVhoaFhYbUR0ZG5DOTB3SC12d0NYcEdrRmNNTlBFU3FvUElTYnl4emFEQmlxMk5Bak1HWUh3?oc=5","date":"2023-12-12","type":"trial","source":"AstraZeneca","summary":"AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data - AstraZeneca","headline":"AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5Kc3B3S2JJZGRnMFp5Q0E0dkt2eHktSnpsUUtpVXNnWjlqNXR3bk9ZNU10OHdSNEZyN2wxMGVEaTYyVklpdllSZHVyNW9SQ0lO?oc=5","date":"2021-09-13","type":"pipeline","source":"The Motley Fool","summary":"Intercept Pharmaceuticals - ICPT - Stock Price & News - The Motley Fool","headline":"Intercept Pharmaceuticals - ICPT - Stock Price & News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPTkFaNUVvcVF5WWdvY2lNX0lCQ0Z2SDFhOGZ0eE5EQkJ0YjJBNjE5U3BvNXpDT0RiM2ZZVGgzSngxdGo1NkVfU0k0emkyWjVrTXVXS01oMmF4VllrWVU0dTNrZWIzUlR0UDVYWEo2cEljNG9hMzFwLWthRGFSbGdEVjlSUExkNEQ0ZE14dmJUS1M5UkE0bzMxSWpoZDRPbk1fNXJQdkpjaHNXOWZmazhuZXAyU0ZNQQ?oc=5","date":"2021-07-29","type":"pipeline","source":"GeekWire","summary":"Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company - GeekWire","headline":"Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":12,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}